missing translation for 'onlineSavingsMsg'
Learn More

Novus Biologicals™ ERK2 Knockout A549 Cell Lysate

Product Code. 18602865 Shop All Bio Techne Products
Click to view available options
Quantity:
100 μg
Unit Size:
100µg
This item is not returnable. View return policy

Product Code. 18602865

Brand: Novus Biologicals™ NBP318632

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Cell Lysate

TRUSTED_SUSTAINABILITY

Specifications

Gene Accession No. P28482, P28482, P28482, P28482
Preparation Method This product has been tested by SDS-PAGE and western blot and is suitable for use in Western blot, ELISA, Immunoprecipitation and ChIP. No detection of expected band at ~44 kDa is observed in MAPK1 (ERK2) knockout A549 when compared with unmodified A549 cell lysates by Western blot.
Quantity 100 μg
Purity Multi-step
Host Species Human
Content And Storage Store at -70°C. Avoid freeze/thaw cycles.
Research Category Angiogenesis, Apoptosis, Breast Cancer, Cancer, Diabetes Research, Hypoxia, Phospho Specific, Protein Kinase, Signal Transduction, Tumor Suppressors
Target ERK2
Synonym EC 2.7.11, EC 2.7.11.24, ERK, ERK-2, ERK2MAP kinase isoform p42, ERT1, Extracellular signal-regulated kinase 2, MAP kinase 1, MAP kinase 2, MAPK 1, MAPK2, mitogen-activated protein kinase 1, Mitogen-activated protein kinase 2, p38, p40, p41, p41mapk, p42-MAPK, P42MAPK, PRKM1MAPK 2, PRKM2, protein tyrosine kinase ERK2
Gene Symbol MAPK1
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.